Showing results (191-200 of 210) with videos related to
Sort By:
Pageof 21
The New Phytologist|February 23, 2026
Shaping future forests: how can ecophysiology support climate-smart forest management?Arthur Gessler, José M Grünzweig, Laura Bigio, et al.The Lancet. Oncology|October 3, 2024
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trialJürgen Wolf, Maximilian Hochmair, Ji-Youn Han, et al.The Journal of Clinical Investigation|February 7, 2018
Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translationVijaykumar Chennupati, Diogo Ft Veiga, Kendle M Maslowski, et al.Cell Host & Microbe|March 19, 2013
Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defensesWendell Smith, Peter Tomasec, Rebecca Aicheler, et al.Cell Death and Differentiation|February 11, 2017
N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced deathFlorent Dufour, Thibault Rattier, Sarah Shirley, et al.Cell|November 21, 2007
IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosisJames E Vince, W Wei-Lynn Wong, Nufail Khan, et al.The EMBO Journal|November 25, 2006
TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regenerationMahasweta Girgenrath, Shawn Weng, Christine A Kostek, et al.Science Immunology|June 17, 2018
ZNF341 controls STAT3 expression and thereby immunocompetenceStefanie Frey-Jakobs, Julia M Hartberger, Manfred Fliegauf, et al.Nature Communications|March 25, 2018
A loop region of BAFF controls B cell survival and regulates recognition by different inhibitorsMichele Vigolo, Melissa G Chambers, Laure Willen, et al.Life Science Alliance|March 8, 2022
LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severityGiuseppe Bombaci, Mayuresh Anant Sarangdhar, Nicola Andina, et al.Pageof 21